MAPKAPK2 |
---|
|
Strwythurau |
---|
PDB | Human UniProt search: PDBe RCSB |
---|
Rhestr o ddynodwyr PDB |
---|
1KWP, 1NXK, 1NY3, 2JBO, 2JBP, 2OKR, 2ONL, 2OZA, 2P3G, 2PZY, 3A2C, 3FPM, 3FYJ, 3FYK, 3GOK, 3KA0, 3KC3, 3KGA, 3M2W, 3M42, 3R2B, 3R2Y, 3R30, 3WI6, 4TYH |
|
|
Dynodwyr |
---|
Cyfenwau | MAPKAPK2, MAPKAP-K2, MK-2, MK2, mitogen-activated protein kinase-activated protein kinase 2, MAPK activated protein kinase 2 |
---|
Dynodwyr allanol | OMIM: 602006 HomoloGene: 56412 GeneCards: MAPKAPK2 |
---|
|
|
Orthologau |
---|
Species | Bod dynol | Llygoden |
---|
Entrez | | |
---|
Ensembl | | |
---|
UniProt | | |
---|
RefSeq (mRNA) | | |
---|
RefSeq (protein) | | |
---|
Lleoliad (UCSC) | n/a | n/a |
---|
PubMed search | [1] | n/a |
---|
Wicidata |
|
Protein sy'n cael ei godio yn y corff dynol gan y genyn MAPKAPK2 yw MAPKAPK2 a elwir hefyd yn Mitogen-activated protein kinase-activated protein kinase 2 (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi ei leoli ar yr edefyn blaen o gromosom dynol 1, band 1q32.1.[2]
Yn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mai'r un genynnau oeddyn nhw. Hefyd mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn MAPKAPK2.
- "A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer. ". Am J Hum Genet. 2012. PMID 22883146.
- "Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. ". Bioorg Med Chem Lett. 2012. PMID 22119462.
- "Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitors. ". J Med Chem. 2015. PMID 25255283.
- "The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells. ". Cell Cycle. 2014. PMID 24556918.
- "The effect of functional MAPKAPK2 copy number variation CNV-30450 on elevating nasopharyngeal carcinoma risk is modulated by EBV infection.". Carcinogenesis. 2014. PMID 24056810.